
Oligoprogressive Renal Cell Carcinoma on Systemic Therapy: Which Patients Benefit from SABR? - Red Journal Podcast August 1, 2026
Send us Fan Mail Sue Yom, Editor in Chief, co-hosts with Section Editor Dr. Bob Dess, Associate Professor and co-Chief of the Genitourinary Radiotherapy Service in the Department of Radiation Oncology at the University o







